Canada - TSX-V:CNVI - CA2059531020 - Common Stock
The current stock price of CNVI.CA is 0.61 CAD. In the past month the price decreased by -11.59%. In the past year, price decreased by -44.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 252.10M | ||
| MIR.CA | MEDMIRA INC | N/A | 56.87M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 48.32M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 27.91M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 22.78M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 20.67M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.53M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 16.77M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 3.98M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K | ||
| IDL.CA | IMAGING DYNAMICS CO LTD | N/A | 413.20K | ||
| VVTM.CA | VVT MED INC | N/A | 20.05M |
Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
CONAVI MEDICAL CORP
76 Berkeley Street
TORONTO ONTARIO CA
Employees: 4
Phone: 14165487522
Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
The current stock price of CNVI.CA is 0.61 CAD. The price decreased by -1.61% in the last trading session.
CNVI.CA does not pay a dividend.
CNVI.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
CNVI.CA stock is listed on the TSX Venture Exchange exchange.
CONAVI MEDICAL CORP (CNVI.CA) currently has 4 employees.
ChartMill assigns a technical rating of 6 / 10 to CNVI.CA. When comparing the yearly performance of all stocks, CNVI.CA is a bad performer in the overall market: 83.03% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to CNVI.CA. CNVI.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months CNVI.CA reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS decreased by -128.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -140.24% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
5 analysts have analysed CNVI.CA and the average price target is 1.02 CAD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 0.61.